• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾肿瘤中的不可逆电穿孔(IRE)

Irreversible Electroporation (IRE) in Renal Tumors.

作者信息

Narayanan Govindarajan, Doshi Mehul H

机构信息

Department of Radiology, Division of Vascular Interventional Radiology, University of Miami Miller School of Medicine, 1475 NW 12th Avenue Grd Fl. C-085, 33136, Miami, FL, USA.

Department of Radiology, Division of Vascular Interventional Radiology, University of Miami Miller School of Medicine, 1475 NW 12th Avenue Grd Fl. C-080, 33136, Miami, FL, USA.

出版信息

Curr Urol Rep. 2016 Feb;17(2):15. doi: 10.1007/s11934-015-0571-1.

DOI:10.1007/s11934-015-0571-1
PMID:26769468
Abstract

Small renal masses (SRMs) have been traditionally managed with surgical resection. Minimally invasive nephron-sparing treatment methods are preferred to avoid harmful consequences of renal insufficiency, with partial nephrectomy (PN) considered the gold standard. With increase in the incidence of the SRMs and evolution of ablative technologies, percutaneous ablation is now considered a viable treatment alternative to surgical resection with comparable oncologic outcomes and better nephron-sparing property. Traditional thermal ablative techniques suffer from unique set of challenges in treating tumors near vessels or critical structures. Irreversible electroporation (IRE), with its non-thermal nature and connective tissue-sparing properties, has shown utility where traditional ablative techniques face challenges. This review presents the role of IRE in renal tumors based on the most relevant published literature on the IRE technology, animal studies, and human experience.

摘要

传统上,小肾肿块(SRMs)的治疗方法是手术切除。为避免肾功能不全的有害后果,微创保肾治疗方法更受青睐,其中部分肾切除术(PN)被视为金标准。随着SRMs发病率的上升和消融技术的发展,经皮消融现在被认为是一种可行的手术切除替代治疗方法,其肿瘤学结局相当,且具有更好的保肾特性。传统的热消融技术在治疗血管或关键结构附近的肿瘤时面临一系列独特的挑战。不可逆电穿孔(IRE)具有非热性质和保留结缔组织的特性,在传统消融技术面临挑战的情况下显示出应用价值。本综述基于关于IRE技术、动物研究和人类经验的最相关已发表文献,阐述了IRE在肾肿瘤中的作用。

相似文献

1
Irreversible Electroporation (IRE) in Renal Tumors.肾肿瘤中的不可逆电穿孔(IRE)
Curr Urol Rep. 2016 Feb;17(2):15. doi: 10.1007/s11934-015-0571-1.
2
Irreversible Electroporation for the Treatment of Small Renal Masses: 5-Year Outcomes.不可逆电穿孔治疗小肾肿瘤:5 年结果。
J Endourol. 2021 Nov;35(11):1586-1592. doi: 10.1089/end.2021.0115. Epub 2021 Aug 18.
3
Initial Assessment of the Efficacy of Irreversible Electroporation in the Focal Treatment of Localized Renal Cell Carcinoma With Delayed-interval Kidney Tumor Resection (Irreversible Electroporation of Kidney Tumors Before Partial Nephrectomy [IRENE] Trial-An Ablate-and-Resect Pilot Study).延迟间隔肾肿瘤切除术聚焦治疗局限性肾细胞癌中不可逆电穿孔疗效的初步评估(肾肿瘤部分肾切除术前不可逆电穿孔[IRENE]试验——一项消融与切除的初步研究)
Urology. 2018 Apr;114:224-232. doi: 10.1016/j.urology.2017.12.016. Epub 2018 Jan 2.
4
A prospective Phase 2a pilot study investigating focal percutaneous irreversible electroporation (IRE) ablation by NanoKnife in patients with localised renal cell carcinoma (RCC) with delayed interval tumour resection (IRENE trial).一项前瞻性2a期试点研究,调查纳米刀对局部肾细胞癌(RCC)患者进行局灶性经皮不可逆电穿孔(IRE)消融并延迟间隔肿瘤切除(IRENE试验)。
Contemp Clin Trials. 2015 Jul;43:10-9. doi: 10.1016/j.cct.2015.05.002. Epub 2015 May 9.
5
A critical analysis of the actual role of minimally invasive surgery and active surveillance for kidney cancer.对肾癌微创手术和主动监测实际作用的批判性分析。
Eur Urol. 2010 Feb;57(2):223-32. doi: 10.1016/j.eururo.2009.10.023. Epub 2009 Oct 20.
6
First Delayed Resection Findings After Irreversible Electroporation (IRE) of Human Localised Renal Cell Carcinoma (RCC) in the IRENE Pilot Phase 2a Trial.IRENE 2a期试点试验中人类局限性肾细胞癌(RCC)不可逆电穿孔(IRE)后的首次延迟切除结果
Cardiovasc Intervent Radiol. 2016 Feb;39(2):239-50. doi: 10.1007/s00270-015-1200-6. Epub 2015 Sep 4.
7
Available ablation energies to treat cT1 renal cell cancer: emerging technologies.可用于治疗 cT1 期肾细胞癌的消融能量:新兴技术。
World J Urol. 2019 Mar;37(3):445-455. doi: 10.1007/s00345-018-2546-6. Epub 2018 Nov 17.
8
Feasibility and safety of irreversible electroporation (IRE) in patients with small renal masses: Results of a prospective study.不可逆电穿孔(IRE)治疗小肾肿瘤的可行性和安全性:一项前瞻性研究结果。
Urol Oncol. 2019 Mar;37(3):183.e1-183.e8. doi: 10.1016/j.urolonc.2018.11.008. Epub 2018 Nov 30.
9
The efficacy and safety of irreversible electroporation for the ablation of renal masses: a prospective, human, in-vivo study protocol.不可逆电穿孔消融肾肿块的疗效与安全性:一项前瞻性人体体内研究方案。
BMC Cancer. 2015 Mar 22;15:165. doi: 10.1186/s12885-015-1189-x.
10
MRI and CT in the follow-up after irreversible electroporation of small renal masses.小肾肿块不可逆电穿孔术后随访中的磁共振成像(MRI)与计算机断层扫描(CT)
Diagn Interv Radiol. 2021 Sep;27(5):654-663. doi: 10.5152/dir.2021.19575.

引用本文的文献

1
Pulsed field ablation in medicine: irreversible electroporation and electropermeabilization theory and applications.医学中的脉冲场消融:不可逆电穿孔和电通透理论与应用
Radiol Oncol. 2025 Feb 27;59(1):1-22. doi: 10.2478/raon-2025-0011. eCollection 2025 Mar 1.
2
Preclinical Study of Biphasic Asymmetric Pulsed Field Ablation.双相不对称脉冲场消融的临床前研究
Front Cardiovasc Med. 2022 Mar 24;9:859480. doi: 10.3389/fcvm.2022.859480. eCollection 2022.
3
Study on Optimal Parameter and Target for Pulsed-Field Ablation of Atrial Fibrillation.

本文引用的文献

1
Minimally Invasive Percutaneous Treatment of Small Renal Tumors with Irreversible Electroporation: A Single-Center Experience.不可逆电穿孔微创经皮治疗小肾肿瘤:单中心经验
J Vasc Interv Radiol. 2015 Oct;26(10):1465-71. doi: 10.1016/j.jvir.2015.06.028. Epub 2015 Aug 4.
2
A prospective Phase 2a pilot study investigating focal percutaneous irreversible electroporation (IRE) ablation by NanoKnife in patients with localised renal cell carcinoma (RCC) with delayed interval tumour resection (IRENE trial).一项前瞻性2a期试点研究,调查纳米刀对局部肾细胞癌(RCC)患者进行局灶性经皮不可逆电穿孔(IRE)消融并延迟间隔肿瘤切除(IRENE试验)。
Contemp Clin Trials. 2015 Jul;43:10-9. doi: 10.1016/j.cct.2015.05.002. Epub 2015 May 9.
3
心房颤动脉冲场消融的最佳参数及靶点研究
Front Cardiovasc Med. 2021 Sep 21;8:690092. doi: 10.3389/fcvm.2021.690092. eCollection 2021.
4
Irreversible electroporation augments checkpoint immunotherapy in prostate cancer and promotes tumor antigen-specific tissue-resident memory CD8+ T cells.不可逆电穿孔增强前列腺癌的检查点免疫治疗,并促进肿瘤抗原特异性组织驻留记忆 CD8+T 细胞。
Nat Commun. 2021 Jun 23;12(1):3862. doi: 10.1038/s41467-021-24132-6.
5
Active surveillance and focal ablation for small renal masses: a better solution for comorbid patients.小肾肿块的主动监测与局部消融:合并症患者的更佳解决方案。
Arch Med Sci. 2019 Jul 11;16(5):1111-1118. doi: 10.5114/aoms.2019.86190. eCollection 2020.
6
Treatment options for localised renal cell carcinoma of the transplanted kidney.移植肾局限性肾细胞癌的治疗选择。
World J Transplant. 2020 Jun 29;10(6):147-161. doi: 10.5500/wjt.v10.i6.147.
7
An evaluation of irreversible electroporation thresholds in human prostate cancer and potential correlations to physiological measurements.人类前列腺癌中不可逆电穿孔阈值的评估及其与生理测量的潜在相关性。
APL Bioeng. 2017 Oct 9;1(1):016101. doi: 10.1063/1.5005828. eCollection 2017 Dec.
8
Focal therapy versus robot-assisted partial nephrectomy in the management of clinical T1 renal masses: A systematic review and meta-analysis.聚焦治疗与机器人辅助部分肾切除术治疗临床T1期肾肿块的系统评价和荟萃分析。
Medicine (Baltimore). 2018 Nov;97(45):e13102. doi: 10.1097/MD.0000000000013102.
9
Irreversible Electroporation: A Novel Ultrasound-guided Modality for Non-thermal Tumor Ablation.不可逆电穿孔:一种新型的超声引导下非热肿瘤消融方式。
J Med Ultrasound. 2017 Oct-Dec;25(4):195-200. doi: 10.1016/j.jmu.2017.08.003. Epub 2017 Oct 6.
10
Percutaneous radiofrequency and microwave ablation in the treatment of renal tumors - 10 years of experience.经皮射频和微波消融治疗肾肿瘤——10年经验
Wideochir Inne Tech Maloinwazyjne. 2017 Dec;12(4):394-402. doi: 10.5114/wiitm.2017.72322. Epub 2017 Dec 29.
The efficacy and safety of irreversible electroporation for the ablation of renal masses: a prospective, human, in-vivo study protocol.
不可逆电穿孔消融肾肿块的疗效与安全性:一项前瞻性人体体内研究方案。
BMC Cancer. 2015 Mar 22;15:165. doi: 10.1186/s12885-015-1189-x.
4
Tissue heterogeneity in structure and conductivity contribute to cell survival during irreversible electroporation ablation by "electric field sinks".组织在结构和电导率方面的异质性通过“电场汇”在不可逆电穿孔消融过程中有助于细胞存活。
Sci Rep. 2015 Feb 16;5:8485. doi: 10.1038/srep08485.
5
Radiofrequency ablation versus partial nephrectomy for clinical T1a renal-cell carcinoma: long-term clinical and oncologic outcomes based on a propensity score analysis.临床T1a期肾细胞癌的射频消融与部分肾切除术:基于倾向评分分析的长期临床和肿瘤学结果
J Endourol. 2015 May;29(5):518-25. doi: 10.1089/end.2014.0864. Epub 2015 Feb 18.
6
Vessel patency post irreversible electroporation.不可逆电穿孔后的血管通畅情况
Cardiovasc Intervent Radiol. 2014 Dec;37(6):1523-9. doi: 10.1007/s00270-014-0988-9. Epub 2014 Sep 12.
7
Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.部分肾切除术与经皮消融术治疗 cT1 期肾肿瘤的比较。
Eur Urol. 2015 Feb;67(2):252-9. doi: 10.1016/j.eururo.2014.07.021. Epub 2014 Aug 6.
8
Long-term oncologic outcomes following radiofrequency ablation with real-time temperature monitoring for T1a renal cell cancer.T1a期肾细胞癌实时温度监测下射频消融后的长期肿瘤学结局
Urol Oncol. 2014 Oct;32(7):1017-23. doi: 10.1016/j.urolonc.2014.03.005. Epub 2014 Jul 2.
9
Planning irreversible electroporation in the porcine kidney: are numerical simulations reliable for predicting empiric ablation outcomes?猪肾不可逆电穿孔治疗规划:数值模拟对预测经验性消融结果是否可靠?
Cardiovasc Intervent Radiol. 2015 Feb;38(1):182-90. doi: 10.1007/s00270-014-0905-2. Epub 2014 May 17.
10
Percutaneous ablation for small renal masses-complications.小肾肿瘤的经皮消融术——并发症
Semin Intervent Radiol. 2014 Mar;31(1):42-9. doi: 10.1055/s-0033-1363842.